819 results
Page 3 of 41
6-K
EX-99.3
40gj57
27 Sep 23
Current report (foreign)
6:06am
6-K
EX-99.2
k94sg 3ppzvqfuzb8
27 Sep 23
Current report (foreign)
6:06am
6-K
EX-99.1
ys7bl5o
27 Sep 23
Current report (foreign)
6:06am
6-K
EX-99.1
5a6c mqt50
5 Sep 23
Sanofi announces changes to its Executive Committee
6:19am
6-K
EX-99.1
06vvz8npompm2w3an1y
10 Aug 23
Recommendation for use in all infants below 8 months of age follows earlier than anticipated FDA approval and unanimous FDA Advisory Committee vote
9:50am
6-K
EX-99.1
sqxhoskqx pvkdkxxp6
28 Jul 23
Solid Q2 performance and strong pipeline momentum
3:35pm
6-K
EX-99.1
shm4syxmb64ger14
28 Jul 23
Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment
9:18am
6-K
EX-99.1
plkje8jmr06m zy09
28 Jul 23
Condensed Half-year Consolidated Financial Statements
7:00am
6-K
EX-99.2
0fjcl
28 Jul 23
Condensed Half-year Consolidated Financial Statements
7:00am
6-K
EX-99.1
t9oz1qul
24 Jul 23
FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
12:43pm
6-K
EX-99.2
2aixij gf
5 Jul 23
Current report (foreign)
8:43am
6-K
EX-99.1
njcc3oe a6
5 Jul 23
Current report (foreign)
8:43am
6-K
EX-99.3
jx238z y4mv5qagyp
5 Jul 23
Current report (foreign)
8:43am
6-K
EX-99.2
sz93t613otj7 v9635fk
20 Jun 23
Current report (foreign)
10:18am
6-K
EX-99.3
28eo sji9s5xd
20 Jun 23
Current report (foreign)
10:18am
6-K
wdg7w9hm0zdtu9
20 Jun 23
Current report (foreign)
10:18am
6-K
EX-99.1
cbj6yhn
20 Jun 23
Current report (foreign)
10:18am
6-K
EX-99.4
hm3q37sm7ep3u
20 Jun 23
Current report (foreign)
10:18am
6-K
EX-99.2
p6zn0 hlzvu
2 Jun 23
Approval of the financial statements for the fiscal year 2022
10:53am
6-K
EX-99.3
1rg4tj
2 Jun 23
Approval of the financial statements for the fiscal year 2022
10:53am